J. Goldman & Co LP Makes New $3.96 Million Investment in Mettler-Toledo International, Inc. $MTD

J. Goldman & Co LP acquired a new position in Mettler-Toledo International, Inc. (NYSE:MTD) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,099 shares of the medical instruments supplier’s stock, valued at approximately $3,959,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. XXEC Inc. purchased a new stake in Mettler-Toledo International during the 2nd quarter worth $77,044,000. BlackRock Inc. acquired a new position in shares of Mettler-Toledo International during the second quarter worth about $2,404,713,000. Capital International Investors boosted its position in shares of Mettler-Toledo International by 12.7% in the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after buying an additional 109,508 shares during the period. T. Rowe Price Investment Management Inc. boosted its position in shares of Mettler-Toledo International by 0.5% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock worth $964,174,000 after buying an additional 3,157 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Mettler-Toledo International by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after buying an additional 14,106 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 417 shares of the business’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the completion of the sale, the director owned 292 shares of the company’s stock, valued at approximately $420,599.72. The trade was a 58.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Shawn Vadala sold 2,240 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the transaction, the chief financial officer directly owned 5,579 shares in the company, valued at $7,989,128. The trade was a 28.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,312 shares of company stock worth $4,750,362 in the last ninety days. 0.71% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

MTD has been the topic of several analyst reports. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Stifel Nicolaus lifted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 4th. Finally, Barclays upped their target price on shares of Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $1,461.27.

Mettler-Toledo International Price Performance

MTD stock opened at $1,402.64 on Wednesday. The stock’s 50 day moving average is $1,329.55 and its two-hundred day moving average is $1,273.83. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The company has a market capitalization of $28.11 billion, a PE ratio of 31.57, a P/E/G ratio of 2.88 and a beta of 1.23. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, beating the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the business posted $10.09 EPS. The business’s revenue was up 4.5% on a year-over-year basis. Analysts predict that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.